AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination

• Published in: Journal of experimental & clinical cancer research 2022-11, Vol.41 (1), p.322-15, Article 322
• Main Authors: Zhao, Rou, He, Baoyu, Bie, Qingli, Cao, Jinghe, Lu, Haoran, Zhang, Zhixin, Liang, Jing, Wei, Li, Xiong, Huabao, Zhang, Bin
• Format: Article
• Language: English
• Subjects: Analysis; AQP5; Aquaporin 5 - genetics; Aquaporin 5 - metabolism; Autophagy; Autophagy-Related Protein-1 Homolog - metabolism; Cancer; Cancer stem cells; Cancer therapies; Carcinogenesis - metabolism; Cell growth; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic - metabolism; Chemotherapy; Development and progression; Drug resistance; Gastric cancer; Genes; Genetic aspects; Humans; Intracellular Signaling Peptides and Proteins - metabolism; LGR5; Ligases; Medical prognosis; Metastasis; Neoplastic Stem Cells - metabolism; Proteins; Proteomics; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; Small intestine; Stem cells; Stomach cancer; Stomach Neoplasms - pathology; Tumors; Ubiquitin; Ubiquitination; ULK1
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-022-02532-w

Cancer stem cells (CSCs) are regarded as the "seed cells" for tumorigenesis, metastasis, recurrence and drug resistance. However, specific surface markers of CSCs of different origins have not been documented. Single-cell sequencing was used to analyze the highly expressed genes in cancer stem cells of gastric cancer patients, and it was verified that AQP5 was specifically highly expressed in gastric cancer stem cells (GC-CSCs) in vivo and in vitro. The effect of AQP5-promoting LGR5 on the malignant biological function of GC-CSCs was investigated. The mechanism by which AQP5 affects GC-CSCs was explored through transcriptome sequencing, proteomic detection, mass spectrometry, etc. RESULTS: We report the identification and validation of AQP5 as a potentially specific surface marker of GC-CSCs. AQP5 was significantly upregulated in CSCs isolated from gastric cancer patients and in spheroid cells, and AQP5 was coexpressed with the canonical stem marker LGR5. Biologically, AQP5 promoted the sphere formation, proliferation, migration and invasion of GC cells in vitro and enhanced tumorigenesis in vivo. Furthermore, AQP5 coordinated with LGR5 and synergistically promoted the tumorigenesis of GC-CSCs. At the mechanistic level, AQP5 activated autophagy by inducing the LC3I/LC3II transformation in GC-CSCs, which was crucial for the biological functions of AQP5. Finally, we demonstrated that AQP5 recruited the E3 ligase TRIM21 to the key autophagy protein ULK1 and induced the K63-mediated ubiquitination of ULK1. We elucidate a novel surface marker, AQP5, which is specifically expressed by GC-CSCs. Furthermore, our study creates a link between AQP5 and LGR5 and highlights the necessity of targeting both surface markers simultaneously as a promising approach for the treatment of gastric cancer patients.